Orchestra Biomed logo

Orchestra Biomed Share Price Today

(NASDAQ: OBIO)

Orchestra Biomed share price is $4.31 & ₹374.84 as on 6 Mar 2025, 2.30 'hrs' IST

$4.31

0.1

(2.38%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Orchestra Biomed share price in Dollar and Rupees. Guide to invest in Orchestra Biomed stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Orchestra Biomed, along with analyst recommendations, forecasts, and comprehensive financials.

Orchestra Biomed share price movements

  • Today's Low: $4.21
    Today's High: $4.57

    Day's Volatility :7.88%

  • 52 Weeks Low: $3.96
    52 Weeks High: $8.87

    52 Weeks Volatility :55.35%

Orchestra Biomed (OBIO) Returns

PeriodOrchestra Biomed Holdings IncIndex (Russel 2000)
3 Months
-15.12%
0.0%
6 Months
-27.29%
0.0%
1 Year
-39.42%
0.0%
3 Years
-63.39%
-11.6%

Orchestra Biomed (OBIO) Key Statistics

in dollars & INR

Previous Close
$4.21
Open
$4.23
Today's High
$4.57
Today's Low
$4.21
Market Capitalization
$155.9M
Today's Volume
$17.0K
52 Week High
$8.8699
52 Week Low
$3.96
Revenue TTM
$2.6M
EBITDA
$-59.8M
Earnings Per Share (EPS)
$-1.6
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-91.66%

How to invest in Orchestra Biomed Stock (OBIO) from India?

It is very easy for Indian residents to invest directly in Orchestra Biomed from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Orchestra Biomed stock in both Indian Rupees (INR) and US Dollars (USD). Search for Orchestra Biomed or OBIO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Orchestra Biomed or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Orchestra Biomed shares which would translate to 0.202 fractional shares of Orchestra Biomed as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Orchestra Biomed, in just a few clicks!

Returns in Orchestra Biomed (OBIO) for Indian investors in Rupees

The Orchestra Biomed stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Orchestra Biomed investment value today

Current value as on today

₹66,977

Returns

₹33,023

(-33.02%)

Returns from Orchestra Biomed Stock

₹37,986 (-37.99%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Orchestra Biomed (OBIO)

-54%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Orchestra Biomed Stock from India on INDmoney has decreased by -54% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Orchestra Biomed

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Orchestra Biomed(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
9
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Orchestra Biomed Stock (OBIO)

What analysts predicted

Upside of 263.5%

Target:

$15.67

Current:

$4.31

Insights on Orchestra Biomed Stock (Ticker Symbol: OBIO)

  • Price Movement

    In the last 1 month, OBIO stock has moved down by -29.6%
  • Increasing Revenue

    Revenue is up for the last 4 quarters, 262.0K → 987.0K (in $), with an average increase of 33.1% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -15.98M → -15.42M (in $), with an average increase of 3.6% per quarter
  • OBIO vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 103.2%
  • Price to Sales

    ForOBIO every $1 of sales, investors are willing to pay $57.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

OBIO Orchestra Biomed Financials in INR & Dollars

FY20Y/Y Change
Revenue
$5.7M
-
Net Income
$-21.4M
-
Net Profit Margin
-374.45%
-
FY21Y/Y Change
Revenue
$-782.0K
↓ 113.71%
Net Income
$-23.0M
↑ 7.77%
Net Profit Margin
2.9K%
↑ 3317.42%
FY22Y/Y Change
Revenue
$3.5M
↓ 551.79%
Net Income
$-33.6M
↑ 46.03%
Net Profit Margin
-951.26%
↓ 3894.23%
FY23Y/Y Change
Revenue
$2.8M
↓ 21.88%
Net Income
$-49.1M
↑ 46.16%
Net Profit Margin
-1.8K%
↓ 828.45%
Q2 FY23Q/Q Change
Revenue
$915.0K
↓ 21.39%
Net Income
$-12.0M
↑ 10.11%
Net Profit Margin
-1.3K%
↓ 376.64%
Q3 FY23Q/Q Change
Revenue
$419.0K
↓ 54.21%
Net Income
$-13.3M
↑ 10.54%
Net Profit Margin
-3.2K%
↓ 1861.54%
Q4 FY23Q/Q Change
Revenue
$262.0K
↓ 37.47%
Net Income
$-12.8M
↓ 3.74%
Net Profit Margin
-4.9K%
↓ 1714.33%
Q1 FY24Q/Q Change
Revenue
$620.0K
↑ 136.64%
Net Income
$-13.5M
↑ 5.03%
Net Profit Margin
-2.2K%
↑ 2720.92%
Q2 FY24Q/Q Change
Revenue
$778.0K
↑ 25.48%
Net Income
$-16.0M
↑ 18.7%
Net Profit Margin
-2.1K%
↑ 117.47%
Q3 FY24Q/Q Change
Revenue
$987.0K
↑ 26.86%
Net Income
$-15.4M
↓ 3.47%
Net Profit Margin
-1.6K%
↑ 491.06%
FY20Y/Y Change
Profit
$5.6M
-
FY21Y/Y Change
Profit
$-981.0K
↓ 117.65%
FY22Y/Y Change
Profit
$3.2M
↓ 427.32%
FY23Y/Y Change
Profit
$2.6M
↓ 19.84%
Q2 FY23Q/Q Change
Profit
$861.0K
↓ 23.12%
Q3 FY23Q/Q Change
Profit
$378.0K
↓ 56.1%
Q4 FY23Q/Q Change
Profit
$179.0K
↓ 52.65%
Q1 FY24Q/Q Change
Profit
$512.0K
↑ 186.03%
Q2 FY24Q/Q Change
Profit
$734.0K
↑ 43.36%
Q3 FY24Q/Q Change
Profit
$919.0K
↑ 25.2%
FY20Y/Y Change
Operating Cash Flow
$-26.2M
-
Investing Cash Flow
$27.0M
-
Financing Cash Flow
$10.0M
-
FY21Y/Y Change
Operating Cash Flow
$-19.4M
↓ 25.8%
Investing Cash Flow
$13.0M
↓ 51.73%
Financing Cash Flow
$-4.0M
↓ 139.93%
Q2 FY23Q/Q Change
Operating Cash Flow
$-10.5M
↓ 27.06%
Investing Cash Flow
$8.1M
↑ 0.0%
Financing Cash Flow
$86.0K
↓ 99.85%

Orchestra Biomed Technicals Summary

Sell

Neutral

Buy

Orchestra Biomed is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Orchestra Biomed (OBIO) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Orchestra Biomed Holdings Inc logo
-24.55%
-27.29%
-39.42%
-63.39%
-63.39%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Orchestra Biomed Holdings Inc logo
NA
NA
NA
-1.66
-0.92
-0.39
NA
1.22
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Orchestra Biomed Holdings Inc logo
Buy
$155.9M
-63.39%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Orchestra Biomed

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold devices and minimally invasive surgery devices. The company has a collaboration agreement with Medtronic, Inc. for the development and commercialization of BackBeat CNT for the treatment of HTN in patients indicated for a cardiac pacemaker; and a strategic collaboration with Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.
Organization
Orchestra Biomed
Employees
56
CEO
Mr. David P. Hochman
Industry
Miscellaneous

Management People of Orchestra Biomed

NameTitle
Mr. David P. Hochman
Founder, Chairman of the Board of Directors & CEO
Mr. Darren R. Sherman
Founder, President, COO & Director
Mr. Andrew Lawrence Taylor M.B.A.
Chief Financial Officer
Dr. Eric A. Rose M.D.
Director Emeritus & Strategic Advisor
Mr. William Reed Little
Executive Vice President of Corporate Development & Strategy
Dr. Yuval Hay Mika D.Sc, Ph.D.
GM & CTO of Bioelectronic Therapies
Dr. George Papandreou Ph.D.
GM & Senior VP of Focal Therapies
Dr. Hans-Peter Stoll M.D., Ph.D.
Chief Clinical Officer
Dr. Avraham Matityahu Fischer M.D.
Senior Vice President of Medical Affairs & Innovation
Mr. Bob Laughner
Senior Vice President of Regulatory & Quality

Important FAQs about investing in OBIO Stock from India :

What is Orchestra Biomed share price today?

Orchestra Biomed share price today stands at $4.31, Open: $4.23 ; Previous Close: $4.21 ; High: $4.57 ; Low: $4.21 ; 52 Week High: $8.87 ; 52 Week Low: $3.96.

The stock opens at $4.23, after a previous close of $4.21. The stock reached a daily high of $4.57 and a low of $4.21, with a 52-week high of $8.87 and a 52-week low of $3.96.

Can Indians buy Orchestra Biomed shares?

Yes, Indians can invest in the Orchestra Biomed (OBIO) from India.

With INDmoney, you can buy Orchestra Biomed at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Orchestra Biomed at zero transaction cost.

How can I buy Orchestra Biomed shares from India?

It is very easy to buy Orchestra Biomed from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Orchestra Biomed (OBIO) be purchased?

Yes, you can buy fractional shares of Orchestra Biomed with INDmoney app.

What are the documents required to start investing in Orchestra Biomed stocks?

To start investing in Orchestra Biomed, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Orchestra Biomed Stock (OBIO)?

Today’s highest price of Orchestra Biomed (OBIO) is $4.57.

Today’s lowest price of Orchestra Biomed (OBIO) is $4.21.

What is today's market capitalisation of Orchestra Biomed?

Today's market capitalisation of Orchestra Biomed OBIO is 155.9M

What is the 52 Week High and Low Range of Orchestra Biomed Stock (OBIO)?

  • 52 Week High

    $8.87

  • 52 Week Low

    $3.96

What are the historical returns of Orchestra Biomed (OBIO)?

  • 1 Month Returns

    -24.55%

  • 3 Months Returns

    -27.29%

  • 1 Year Returns

    -39.42%

  • 5 Years Returns

    -63.39%

Who is the Chief Executive Officer (CEO) of Orchestra Biomed ?

Mr. David P. Hochman is the current Chief Executive Officer (CEO) of Orchestra Biomed.